COVID-19 and restrictive lung disease: A deadly combo to trip off the fine balance

https://doi.org/10.4081/monaldi.2020.1346

Authors

  • Kamal Kant Sahu | drkksahu85@gmail.com Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, United States. https://orcid.org/0000-0002-0382-6882
  • Ajay Kumar Mishra Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, United States. https://orcid.org/0000-0003-4862-5053
  • Kevin Martin Division of Pulmonary and Critical Care, Department of Internal Medicine, Worcester, MA, United States. https://orcid.org/0000-0001-7915-6515
  • Iryna Chastain Department of Internal Medicine, Saint Vincent Hospital, Worcester, MA, United States.

Abstract

Coronavirus Disease (COVID-19) pandemic has so far led to innumerable deaths worldwide. The risk factors so far that have been most studied as poor prognostic factors are old age, individuals with multiple comorbidities and immunocompromised patients. Amongst the chronic lung diseases, most patients with COVID-19 reported so far had asthma, chronic obstructive pulmonary disease (COPD), and interstitial lung disease. Herein, we discuss the significance of restrictive lung disease during the COVID-19 pandemic as a potential risk factor via an example of a patient with kyphoscoliosis who succumbed to death due to COVID-19 pneumonia.

Dimensions

Altmetric

PlumX Metrics

Downloads

Download data is not yet available.

Downloads

Published
2020-06-29
Info
Issue
Section
COVID-19 - Collection of articles on the Coronavirus outbreak
Keywords:
COVID-19, virus, lung, kyphoscoliosis
Statistics
  • Abstract views: 2309

  • PDF: 822
How to Cite
Sahu, Kamal Kant, Ajay Kumar Mishra, Kevin Martin, and Iryna Chastain. 2020. “COVID-19 and Restrictive Lung Disease: A Deadly Combo to Trip off the Fine Balance”. Monaldi Archives for Chest Disease 90 (2). https://doi.org/10.4081/monaldi.2020.1346.

Most read articles by the same author(s)